loading page

Successful ECMO therapy in a child with COVID-19-associated ARDS and Ewing's Sarcoma.
  • +4
  • Carmen Niño-Taravilla,
  • Yuri Zuleta-Morales,
  • Benigno Montenegro,
  • Cristian Sotomayor,
  • Claudia Greppi Q.,
  • Pamela Silva-Garay,
  • Paula Ortiz-Fritz
Carmen Niño-Taravilla
Hospital de Ninos Roberto del Rio

Corresponding Author:[email protected]

Author Profile
Yuri Zuleta-Morales
Hospital de Ninos Roberto del Rio
Author Profile
Benigno Montenegro
Hospital de Ninos Roberto del Rio
Author Profile
Cristian Sotomayor
Hospital de Ninos Roberto del Rio
Author Profile
Claudia Greppi Q.
Hospital de Ninos Roberto del Rio
Author Profile
Pamela Silva-Garay
Hospital de Ninos Roberto del Rio
Author Profile
Paula Ortiz-Fritz
Hospital de Ninos Roberto del Rio
Author Profile

Abstract

Most children and adolescents with SARS-CoV-2 infection shows asymptomatically or with mild symptoms. There are few reported cases of extracorporeal membrane oxygenation (ECMO) in pediatric patients with coronavirus disease 2019 (COVID-19). We present a previously healthy 13-year-old male, diagnosed with metastatic Ewing’s sarcoma at the same time as catastrophic acute respiratory distress syndrome due to COVID-19, which was successfully supported by veno-venous ECMO, while he received the corresponding chemotherapy protocol. ECMO can be used as salvage therapy in oncology pediatric patients with respiratory failure secondary to COVID-19. In addition, successful chemotherapy can be administered while patients are supported on ECMO.